181 related articles for article (PubMed ID: 34155573)
1. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
[TBL] [Abstract][Full Text] [Related]
2. Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
Pang R; Zhao J; Gan Z; Hu Z; Xue X; Wu Y; Qiao Q; Zhong A; Xia X; Liao H; Wang Z; Zhang L
Aging (Albany NY); 2020 Dec; 12(23):23427-23435. PubMed ID: 33289698
[TBL] [Abstract][Full Text] [Related]
3. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
Frommert LM; Arumahandi de Silva AN; Zernicke J; Scholz V; Braun T; Jeworowski LM; Schwarz T; Tober-Lau P; Ten Hagen A; Habermann E; Kurth F; Sander LE; Corman VM; Burmester GR; Biesen R; Albach FN; Klotsche J
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36597977
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey.
Misra R; Bhattacharya D; Ahmed S; Amin S; Shobha V; Ghosh A; Pandya SC; Parai D; Padhan P; Priyadarshini S; Mohapatra I; Patro ARK; Mohanty AP; Pati S
Rheumatol Int; 2024 Jan; 44(1):81-87. PubMed ID: 37906254
[TBL] [Abstract][Full Text] [Related]
5. The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.
Lakota K; Perdan-Pirkmajer K; Sodin-Šemrl S; Čučnik S; Šubelj V; Prosenc K; Mrak Poljšak K; Tomšič M; Ambrožič A; Praprotnik S
Clin Rheumatol; 2019 May; 38(5):1277-1292. PubMed ID: 30761436
[TBL] [Abstract][Full Text] [Related]
6. Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan.
Yamaguchi Y; Nameki S; Kato Y; Saita R; Sato T; Nagao S; Murakami T; Yoshimine Y; Amiya S; Morita T; Okita Y; Kawasaki T; Fujimoto J; Ueda Y; Maeda Y; Watanabe A; Takamatsu H; Nishida S; Shima Y; Narazaki M; Kumanogoh A
Lancet Reg Health West Pac; 2023 Mar; 32():100661. PubMed ID: 36569794
[TBL] [Abstract][Full Text] [Related]
7. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
[TBL] [Abstract][Full Text] [Related]
9. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.
Van Doornum S; Bohensky M; Tacey MA; Brand CA; Sundararajan V; Wicks IP
Arthritis Res Ther; 2015 Feb; 17(1):38. PubMed ID: 25879786
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.
Akkuzu G; Bes C; Özgür DS; Karaalioğlu B; Mutlu MY; Yıldırım F; Atagündüz P; Gündüz A; Soy M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2143-2151. PubMed ID: 36930514
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evolution and levels of anti-S SARS-CoV-2 IgG in rheumatic disease and COVID-19].
Medina GA; Pino M; Geffner J; Perrotta NA; Barrios CV
Medicina (B Aires); 2021; 81(6):902-907. PubMed ID: 34875586
[TBL] [Abstract][Full Text] [Related]
12. Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
Arumahandi de Silva AN; Frommert LM; Albach FN; Klotsche J; Scholz V; Jeworowski LM; Schwarz T; Ten Hagen A; Zernicke J; Corman VM; Drosten C; Burmester GR; Biesen R
Ann Rheum Dis; 2022 Jun; 81(6):881-888. PubMed ID: 35288376
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
[TBL] [Abstract][Full Text] [Related]
14. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia.
Dong X; Zheng Y; Wang L; Chen WH; Zhang YG; Fu Q
Clin Rheumatol; 2018 Apr; 37(4):1027-1035. PubMed ID: 28748510
[TBL] [Abstract][Full Text] [Related]
16. Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
Boekel L; Hooijberg F; Vogelzang EH; Besten YR; Leeuw M; Atiqi S; van Vollenhoven RF; Wijbrandts CA; Gerritsen M; Krieckaert C; Dijkshoorn B; Bakhlakh S; Crooijmans JJ; Voskuyl A; van der Horst-Bruinsma IE; Lems W; Kuijpers TW; van Ham SM; Wieske L; Eftimov F; Kummer LY; van Dam PK; Stalman EW; Steenhuis M; Keijzer S; Cristianawati O; Keijser J; Loeff FC; Tas SW; Nurmohamed MT; Boers M; Rispens T; Wolbink G
RMD Open; 2022 Apr; 8(1):. PubMed ID: 35383121
[TBL] [Abstract][Full Text] [Related]
17. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.
Saxena A; Guttmann A; Masson M; Kim MY; Haberman RH; Castillo R; Scher JU; Deonaraine KK; Engel AJ; Belmont HM; Blazer AD; Buyon JP; Fernandez-Ruiz R; Izmirly PM;
Lancet Rheumatol; 2021 Aug; 3(8):e585-e594. PubMed ID: 34075358
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 outcomes in patients with and without autoimmune rheumatic diseases: A multicenter comparative study.
Abdulnaby NK; Gamal SM; Alkemary A; Abdo M; Sabry IM; Belita MI; Mohamed SS
Int J Rheum Dis; 2023 May; 26(5):870-877. PubMed ID: 36929695
[TBL] [Abstract][Full Text] [Related]
20. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Lumley SF; Wei J; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Peck LJ; Ritter TG; de Toledo Z; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Crook DW; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Walker TM; Jeffery K; Eyre DW;
Clin Infect Dis; 2021 Aug; 73(3):e699-e709. PubMed ID: 33400782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
